Importantly, FABP4 contributes to the tumor transformation, proliferation, metastasis and therapy resistance by enhancing lipid transport and activating diverse oncogenic signaling pathways (Guaita-Esteruelas et al., 2018). The gene discussed is FABP4; the disease is neoplasm.